SEATTLE, Oct. 05, 2023 (GLOBE NEWSWIRE) — Avalyn Pharma Inc., a clinical-stage biopharmaceutical company focused on development of targeted inhalation therapies for life-threatening pulmonary diseases, today announced that Lyn Baranowski, chief executive officer of Avalyn, will provide a corporate overview and be available for 1×1 meetings at three upcoming investor…Read More
Avalyn to Participate in Multiple Upcoming Investor Conferences
